NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDDK E-013-2009-0-US-01 IMAGE CONTRAST ENHANCEMENT FOR IN VIVO OXYGENATION MEASUREMENTS DURING SURGERY US 61/120,971 Abandoned
NCI E-166-2007-0-CA-03 DOC1 Compositions and Methods for Treating Cancer CA National Stage 2706317 Abandoned
NCI E-166-2007-0-GB-10 DOC1 Compositions and Methods for Treating Cancer GB EP 08878051.5 Issued
NCI E-166-2007-0-FR-09 DOC1 Compositions and Methods for Treating Cancer FR EP 08878051.5 Issued
NCI E-166-2007-0-DE-08 DOC1 Compositions and Methods for Treating Cancer DE EP 08878051.5 Issued
NCI E-166-2007-0-EP-04 DOC1 Compositions and Methods for Treating Cancer EP National Stage 08878051.5 Issued
NCI E-093-1996-3-JP-17 02-Arylated Or O2-Glycosylated 1-Substituted Diazen -1-Ium-1, 2-Diolates And O2-Substitued 1-[(2-Carboxylato) Pyrrolidin-1-yl] Diazen -1-Ium-1, 2-Diolates JP DIV 2008-311808 Expired
NCI E-166-2007-0-PCT-02 DOC1 Compositions and Methods for Treating Cancer PCT PCT PCT/IB2008/005015 Expired
NCI E-336-2008-0-AU-02 BLOCKING MESOTHELIN PEPTIDE FRAGMENTS AU National Stage 2008364786 Abandoned
NCI E-336-2008-0-US-04 Blocking Mesothelin Peptide Fragments US National Stage 13/133,136 8623828 Abandoned PDF
NCI E-336-2008-0-PCT-01 BLOCKING MESOTHELIN PEPTIDE FRAGMENTS PCT PCT PCT/US2008/85743 Expired
NIAID E-055-2009-0-US-01 Use of a ROCK Inhibitor to Sustain Primary Human Keratinocytes in a Proliferative State US 61/120,272 Abandoned
NIAID E-004-2009-1-US-01 Use Of Viral Like Particles (VLPs) In The Development Of A Preventive Vaccine Against Chikungunya US 61/201,118 Abandoned
NCI E-336-2008-0-CA-03 BLOCKING MESOTHELIN PEPTIDE FRAGMENTS CA National Stage 2745798 Abandoned
NCI E-296-2008-0-US-01 ANTI-CANCER OLIGODEOXYNUCLEOTIDES US 61/119,998 Abandoned
NIMH E-054-2009-0-US-01 PIK3CD DRUGS FOR THE TREATMENT OF PSYCHOSIS AND COGNITIVE DEFICIENCY US 61/119,978 Abandoned
NHLBI E-321-2007-0-PCT-02 Apparatus for Countercurrent Chromatography PCT PCT PCT/US2008/085439 Expired
CC E-036-2009-0-US-01 A Feedback System For Integrating Interventiona! Planning And Navigation US 61/119,464 Abandoned
NIEHS E-016-2007-0-PCT-02 IDENTIFICATION AND DIAGNOSIS OF PULMONARY FIBROSIS USING MUCIN GENES, AND RELATED METHODS AND COMPOSITIONS PCT PCT PCT/US2008/013271 Expired
NCI E-262-1999-1-US-03 HGF-SF Monoclonal Antibody Combinations US DIV 12/326,602 Abandoned
NCI E-250-2008-0-US-01 In Vivo Quantitative Tissue Oxygen Imaging Using Pulsed Time-Domain Electron Paramagnetic Resonance Using A Combination Of Electron Spin-Echo And Single Point Imaging - ESPI (Echo-based Single Point Imaging) US 61/200,579 Abandoned
NIAID E-004-2009-0-US-01 Use Of Viral Like Particles (VLPs) In The Development Of A Preventive Vaccine Against Chikungunya US 61/118,206 Abandoned
NIAMS E-028-2006-0-US-04 A Novel Predictive Marker Of Disease Severity In Inflammatory Diseases US National Stage 12/089,843 Abandoned
NHLBI E-330-2008-0-US-01 Shimming Of Static Magnetic Field For Cardiovascular Magnetic Resonance Imaging Applications US 61/117,667 Abandoned
NIAMS E-224-2010-0-US-01 A nanofiberous conduit seeded with muscle-derived mesenchymal progenitor cells US 61/117,814 Abandoned
NIAID E-031-2004-3-US-02 Anti-Tubercular Drug: Compositions And Methods US CON 12/276,893 Abandoned
NEI E-314-2003-2-US-02 PEDF-R Receptor And Uses US National Stage 10/566,540 Abandoned
NHLBI E-188-2006-0-US-03 Erythroid Progenitor Cells And Methods For Producing Parvovirus B19 Therein US National Stage 12/301,960 Abandoned
NHGRI E-167-2001-2-US-08 Methods And Compositions For The Repair And/or Regeneration Of Damaged Myocardium US CON 12/274,125 Expired
NCATS E-267-2008-0-US-01 Substituted Triazines As Inhibitors Of Cruzain And Rhodesain And As Front Line Therapies For Chagas' Disease And African Trypanosomiasis US 61/199,763 Abandoned
NIAID E-125-2008-0-US-01 MONOCLONAL ANTIBODIES THAT REACT WITH THE CAPSULE OF BACILLUS ANTHRACIS US 61/116,222 Abandoned
NCI E-040-2009-0-US-01 Electrical Percolation Biological Semiconductors US 61/115,846 Abandoned
NIDA E-176-2008-0-US-01 Differentiation Of Human Embryonic Stem Cells Into Dopaminergic Cells US 61/199,652 Abandoned
NCI E-207-2005-2-US-01 Quantitative Measurement Of Fifteen Conjugated And Non-conjugated Estrogen Metabolitets In Blood By LC/MS US CIP 12/272,015 Abandoned
NIDDK E-223-2006-1-US-01 PYRIMIDINE LOW MOLECULAR WEIGHT LIGANDS FOR MODULATING HORMONE RECEPTORS US CIP 12/291,932 Abandoned
NCI E-019-2009-0-US-01 Human Herpesvirus 6A (HHV6A) Quantitative Real-Time PCR Array US 61/114,753 Abandoned
NCI E-248-2005-0-PCT-02 NITRIC OXIDE-RELEASING DIAZENIUMDIOLATED POLYMERS, COMPOSITIONS, MEDICAL DEVICES, AND USES THEREOF PCT PCT PCT/US08/83375 Abandoned
NHGRI E-272-2008-0-US-01 USE OF ERBB4 AS A PROGNOSTIC MARKER FOR MELANOMA US 61/199,156 Abandoned
NIAID E-146-2008-1-US-01 Induction Of Profliferation, Molecule Expression And Cytolytic Capacity Of HIV -Specific CD8 + T Cells US 61/199,126 Abandoned
NCI E-137-2006-1-US-01 Manganese Superoxide Dismutase VAL16ALA Polymorphism Predicts Resistance to Chemotherapeutic Drug Cancer Therapy US National Stage 12/268,655 7985561 Abandoned PDF
NCI E-189-2002-0-US-07 POLYDIAZENIUMDIALATED CYCLIC POLYAMINES WITH POLYPHASIC NITRIC OXIDE RELEASE AND RELATED COMPOUNDS, COMPOSITIONS COMPRISING SAME AND... US DIV 12/268,855 7928096 Abandoned PDF
NIAID E-003-2005-0-US-03 Methods of treating and preventing inflammatory bowel disease involving il-13 and nkt cells US National Stage 11/918,711 9072716 Issued PDF
NCI E-012-2008-0-PCT-02 C4' -SUBSTITUTED-2-DEOXYADENOSINE ANALOGS AND METHODS OF TREATING HIV PCT PCT PCT/US2008/012663 Expired
NIAID E-275-2000-3-US-07 Modifications Of HIV Enhance Immunogenicity For Genetic Immunization US DIV 12/291,533 Abandoned
NCI E-012-2008-0-EP-04 C4' -SUBSTITUTED-2-DEOXYADENOSINE ANALOGS AND METHODS OF TREATING HIV EP National Stage 08850780.1 Abandoned
NCI E-012-2008-0-EP-05 C4' -SUBSTITUTED-2-DEOXYADENOSINE ANALOGS AND METHODS OF TREATING HIV EP National Stage 885078.1 Abandoned
NCI E-024-2009-0-US-01 Molecular Prediction Of Survival Outcome Of Human Hepatocellular Carcinoma (HCC) Patients By A 'driver'-gene-signature. US 61/198,813 Abandoned
NICHD E-339-2008-1-US-01 A Mutlicomponent Vaccine For Malaria Providing Long-lasting Immune Responses Against Plasmodia. US 61/112,527 Abandoned
NIAID E-238-2008-1-US-01 Device For Microwave-assisted Cryo-sample Processing US 61/112,575 Abandoned
NIDCR E-003-1999-0-US-19 Nucleic Acids Encoding a G-protein Coupled Receptor Involved in Taste Transduction. US CON 12/266,419 Abandoned